Atlas Trials

Evaluating a Nitric Oxide Generator, Nebivolol as a Disease Modifier in Patients With Diabetic Neuropathy.

Clinical trial NCT06201611 · RECRUITING

Trial details

NCT number
NCT06201611
Sponsor
St. John's Research Institute
Status
RECRUITING
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Diabetic Neuropathy Peripheral
Start date
2024-11-15
Primary completion
2025-12-30
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.